- Investing Ideas
- /
- Swedish Healthcare Undervalued based on future growth
Swedish Healthcare Undervalued based on future growth
Results
5
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
5 companies
Humana
Market Cap: SEK 2.0b
Provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark.
HUM
SEK 39.85
7D
-9.7%
1Y
39.8%
Paxman
Market Cap: SEK 1.5b
Develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.
PAX
SEK 70.40
7D
4.8%
1Y
86.2%
C-Rad
Market Cap: SEK 1.0b
Develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific.
CRAD B
SEK 30.00
7D
1.9%
1Y
-22.5%
ADDvise Group
Market Cap: SEK 836.5m
Supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally.
ADDV A
SEK 3.37
7D
-10.6%
1Y
-75.8%
Arcoma
Market Cap: SEK 117.6m
Develops, produces, and provides radiology solutions and digital x-ray systems worldwide.
ARCOMA
SEK 8.92
7D
-3.0%
1Y
-33.9%